Answers are grounded in this paper and cite their sources.
. ASO treatment successfully restored enzymatic activity, particularly in fibroblast lines, with residual activity exceeding 1% of normal. These findings suggest that ASO-mediated splicing correction targeting the 84-bp pseudoexon can restore mRNA, protein, and enzymatic function in individuals with deep intronic mutations, as well as in other individuals with propionic acidemia, indicating the feasibility of ASO therapy as a molecular treatment strategy for a subset of individuals with propionic acidemia.
No takes yet. Share an insight, caveat, or question.
Totsune et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: